Constructive Self Assertiveness Via the Internet (R2)

April 16, 2024 updated by: Per Carlbring, Stockholm University

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated.

In a randomized controlled trial three groups will be compared:

  1. constructive self-assertiveness with guidance
  2. constructive self-assertiveness without guidance
  3. Waitlist control

Study Overview

Detailed Description

Some people have problems with self-assertiveness. That can have negative impact on their lives. This study will test a constructive self-assertiveness intervention program delivered online. In addition, the relative effect of guidance during the intervention will be investigated.

In a randomized controlled trial three groups will be compared:

  1. constructive self-assertiveness with guidance
  2. constructive self-assertiveness without guidance
  3. Waitlist control

The treatment (and wait) will be 10 weeks.

Study Type

Interventional

Enrollment (Actual)

210

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 10691
        • Department of Psychology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Human,
  • At least 18 years old,
  • Able to speak and read Swedish,
  • Informed consent.

Exclusion Criteria:

  • Severe depression (as defined by a PHQ9 score of 15 points or higher),
  • If on medication the dosage has been stable for at least the past 3 months,
  • No ongoing psychotherapy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Constructive self-assertiveness with guidance
10 weeks of internet-based treatment with weekly assignments. The homework is commented on by the guide using electronic communication.
Participants will get one "chapter" a week to work with. All chapters are presented on web pages and include information and exercises and end with homework assignments.
Experimental: Constructive self-assertiveness without guidance
10 weeks of internet-based treatment with weekly assignments. The homework is NOT commented on by any guide. Hence, same treatment as group 1 but without guidance.
Participants will get one "chapter" a week to work with. All chapters are presented on web pages and include information and exercises and end with homework assignments.
No Intervention: Waitlist control
No treatment, no guidance, just waiting for 10 weeks. After the ten weeks the participants will receive the treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adaptive and Aggressive Assertiveness Scale
Time Frame: Up to 12 months
A self-report questionnaire measuring Adaptive and Aggressive Assertiveness. Higher scores mean a worse outcome. Minimum and maximum values: 30-150.
Up to 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire 9-item
Time Frame: Up to 12 months
Depression questionnaire. Higher scores mean a worse outcome. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.
Up to 12 months
Generalized Anxiety Disorder 7
Time Frame: Up to 12 months
General Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-27.
Up to 12 months
Liebowitz Social Anxiety Scale , self-report
Time Frame: Up to 12 months
Social Anxiety questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: 0-144.
Up to 12 months
Rathus Assertiveness Schedule
Time Frame: Up to 12 months
Assertiveness questionnaire. Higher scores mean a worse outcome. Minimum and maximum values: -30 to +30.
Up to 12 months
Well-being scale
Time Frame: Up to 12 months
Depression scale. Lower scores mean a worse outcome. Minimum and maximum values: 0-72.
Up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2020

Primary Completion (Actual)

May 16, 2021

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

January 15, 2020

First Submitted That Met QC Criteria

January 23, 2020

First Posted (Actual)

January 27, 2020

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RESPECT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Analytic code and pseudoanonymous data in a data repository.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Problems With Self-assertiveness

Clinical Trials on Constructive self-assertiveness program via the internet

Subscribe